Germline genetic testing in advanced prostate cancer; practices and barriers: survey results from the Germline Genetics Working Group of the Prostate Cancer Clinical …

CJ Paller, ES Antonarakis, TM Beer, HT Borno… - Clinical genitourinary …, 2019 - Elsevier
Background Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …
被引用次数：59 相关文章

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

CJ Paller, ES Antonarakis, TM Beer… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

PCCTC Germline Genetics … - Clinical …, 2019 - scholars.northwestern.edu
Background: Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

PCCTC Germline Genetics Working … - Clinical Genitourinary …, 2019 - pure.johnshopkins.edu
Background: Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

CJ Paller, ES Antonarakis, TM Beer… - Clinical Genitourinary …, 2019 - europepmc.org
Background Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …
[HTML] nih.gov

[HTML][HTML] Germline Genetic Testing in Advanced Prostate Cancer-Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate …

CJ Paller, ES Antonarakis, TM Beer… - Clinical genitourinary …, 2019 - ncbi.nlm.nih.gov
Background: Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

CJ Paller, ES Antonarakis… - Clinical …, 2019 - clinical-genitourinary-cancer.com
Background Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

PCCTC Germline Genetics Working … - Clinical Genitourinary …, 2019 - ohsu.elsevierpure.com
Background: Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …
[HTML] umn.edu

[HTML][HTML] Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate …

PCCTC Germline Genetics Working … - Clinical Genitourinary …, 2019 - experts.umn.edu
BACKGROUND: Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer …

C Paller, E Antonarakis, T Beer, H Borno… - Clinical Genitourinary …, 2019 - escholarship.org
BACKGROUND: Germline genetic testing increasingly identifies advanced prostate cancer
(PCa) patients who are candidates for precision therapies. The Prostate Cancer Clinical …